Abstract

These guidelines for the treatment of persons who have or are at risk for sexually transmitted infections (STIs) were updated by CDC after consultation with professionals knowledgeable in the field of STIs who met in Atlanta, Georgia, June 11-14, 2019. The information in this report updates the 2015 guidelines. These guidelines discuss 1) updated recommendations for treatment of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis; 2) addition of metronidazole to the recommended treatment regimen for pelvic inflammatory disease; 3) alternative treatment options for bacterial vaginosis; 4) management of Mycoplasma genitalium; 5) human papillomavirus vaccine recommendations and counseling messages; 6) expanded risk factors for syphilis testing among pregnant women; 7) one-time testing for hepatitis C infection; 8) evaluation of men who have sex with men after sexual assault; and 9) two-step testing for serologic diagnosis of genital herpes simplex virus. Physicians and other health care providers can use these guidelines to assist in prevention and treatment of STIs.

Keywords

MedicineMycoplasma genitaliumBacterial vaginosisSyphilisChlamydia trachomatisPelvic inflammatory diseaseChlamydiaTrichomonas vaginalisNeisseria gonorrhoeaeGynecologySexually transmitted diseaseGonorrheaFamily medicineMetronidazoleAzithromycinImmunologyHuman immunodeficiency virus (HIV)Antibiotics

MeSH Terms

Centers for Disease Control and PreventionU.S.HumansSexually Transmitted DiseasesUnited States

Related Publications

Publication Info

Year
2021
Type
article
Volume
70
Issue
4
Pages
1-187
Citations
2158
Access
Closed

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

2158
OpenAlex
156
Influential
1711
CrossRef

Cite This

Kimberly Workowski, Laura H. Bachmann, Philip A. Chan et al. (2021). Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recommendations and Reports , 70 (4) , 1-187. https://doi.org/10.15585/mmwr.rr7004a1

Identifiers

DOI
10.15585/mmwr.rr7004a1
PMID
34292926
PMCID
PMC8344968

Data Quality

Data completeness: 86%